|
HSPA4L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.857890E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.840400E-01 |
| Normal-vs-Stage2 |
5.332800E-01 |
| Normal-vs-Stage3 |
1.11990000051243E-07 |
| Normal-vs-Stage4 |
1.73560000005235E-06 |
| Stage1-vs-Stage2 |
5.747400E-01 |
| Stage1-vs-Stage3 |
3.90370002989471E-09 |
| Stage1-vs-Stage4 |
8.13350000017365E-07 |
| Stage2-vs-Stage3 |
9.393500E-04 |
| Stage2-vs-Stage4 |
7.427300E-04 |
| Stage3-vs-Stage4 |
6.527000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.226000E-02 |
| Normal-vs-AfricanAmerican |
6.698000E-03 |
| Normal-vs-Asian |
9.252200E-01 |
| Caucasian-vs-AfricanAmerican |
1.589810E-01 |
| Caucasian-vs-Asian |
5.766800E-01 |
| AfricanAmerican-vs-Asian |
2.133800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.782500E-04 |
| Normal-vs-Female |
9.208800E-01 |
| Male-vs-Female |
4.025700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.969870E-04 |
| Normal-vs-Age(41-60Yrs) |
1.743010E-01 |
| Normal-vs-Age(61-80Yrs) |
1.136250E-02 |
| Normal-vs-Age(81-100Yrs) |
8.693000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.115710E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.253700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.441800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.084400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.965000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.441000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.589500E-02 |
| Normal-vs-Grade 2 |
9.732200E-01 |
| Normal-vs-Grade 3 |
2.095900E-03 |
| Normal-vs-Grade 4 |
1.48720036285965E-10 |
| Grade 1-vs-Grade 2 |
2.925000E-01 |
| Grade 1-vs-Grade 3 |
1.780090E-02 |
| Grade 1-vs-Grade 4 |
1.66560000003368E-06 |
| Grade 2-vs-Grade 3 |
1.677720E-03 |
| Grade 2-vs-Grade 4 |
4.85429474395005E-11 |
| Grade 3-vs-Grade 4 |
4.13650000000709E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.636300E-02 |
| Normal-vs-ccB subtype |
1.025610E-04 |
| ccA subtype-vs-ccB subtype |
5.6190000430334E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.241980E-01 |
| Normal-vs-N1 |
6.743800E-02 |
| N0-vs-N1 |
1.962610E-01 |
|
|
